Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PARP1 and PARP2 stabilise replication forks at base excision repair intermediates through Fbh1-dependent Rad51 regulation
George E. Ronson, Ann Liza Piberger, Martin R. Higgs, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 179

Showing 1-25 of 179 citing articles:

PARP and PARG inhibitors in cancer treatment
Dea Slade
Genes & Development (2020) Vol. 34, Iss. 5-6, pp. 360-394
Open Access | Times Cited: 525
The comings and goings of PARP-1 in response to DNA damage
John M. Pascal
DNA repair (2018) Vol. 71, pp. 177-182
Open Access | Times Cited: 299
Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.
Manendra Singh Tomar, Ashok Kumar, Chhitij Srivastava, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188616-188616
Closed Access | Times Cited: 201
Role of BRCA Mutations in Cancer Treatment with Poly(ADP-ribose) Polymerase (PARP) Inhibitors
Isabella Faraoni, Grazia Graziani
Cancers (2018) Vol. 10, Iss. 12, pp. 487-487
Open Access | Times Cited: 196
Multifaceted Role of PARP-1 in DNA Repair and Inflammation: Pathological and Therapeutic Implications in Cancer and Non-Cancer Diseases
Simonetta Pazzaglia, Claudio Pioli
Cells (2019) Vol. 9, Iss. 1, pp. 41-41
Open Access | Times Cited: 172
XRCC1 prevents toxic PARP1 trapping during DNA base excision repair
Annie Albert Demin, Kouji Hirota, Masataka Tsuda, et al.
Molecular Cell (2021) Vol. 81, Iss. 14, pp. 3018-3030.e5
Open Access | Times Cited: 144
Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies
Jixuan Gao, Hilda A. Pickett
Nature reviews. Cancer (2022) Vol. 22, Iss. 9, pp. 515-532
Closed Access | Times Cited: 139
ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells
Priyanka Verma, Yeqiao Zhou, Zhendong Cao, et al.
Nature Cell Biology (2021) Vol. 23, Iss. 2, pp. 160-171
Open Access | Times Cited: 122
DNA single-strand break repair and human genetic disease
Keith W. Caldecott
Trends in Cell Biology (2022) Vol. 32, Iss. 9, pp. 733-745
Closed Access | Times Cited: 110
Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper
Giuditta Illuzzi, Anna D. Staniszewska, Sonja J. Gill, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 21, pp. 4724-4736
Open Access | Times Cited: 96
METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability
Huafu Li, Chunming Wang, Linxiang Lan, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 80
Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies
Antonella Padella, Andrea Ghelli Luserna di Rorà, Giovanni Marconi, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 71
Revolutionizing DNA repair research and cancer therapy with CRISPR–Cas screens
Samah W. Awwad, Almudena Serrano-Benítez, John C. Thomas, et al.
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 7, pp. 477-494
Closed Access | Times Cited: 48
Nuclear Actin and Actin-Binding Proteins in DNA Repair
Verena Hurst, Kenji Shimada, Susan M. Gasser
Trends in Cell Biology (2019) Vol. 29, Iss. 6, pp. 462-476
Open Access | Times Cited: 119
Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature Review
Stergios Boussios, Peeter Karihtala, Michele Moschetta, et al.
Diagnostics (2019) Vol. 9, Iss. 3, pp. 87-87
Open Access | Times Cited: 119
Restored replication fork stabilization, a mechanism of PARP inhibitor resistance, can be overcome by cell cycle checkpoint inhibition
Brittany Haynes, Junko Murai, Jung‐Min Lee
Cancer Treatment Reviews (2018) Vol. 71, pp. 1-7
Open Access | Times Cited: 105
Nuclear PARPs and genome integrity
Kameron Azarm, Susan Smith
Genes & Development (2020) Vol. 34, Iss. 5-6, pp. 285-301
Open Access | Times Cited: 98
DNA Damage Response and Immune Defense
Claudia Nastasi, Laura Mannarino, Maurizio D’Incalci
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7504-7504
Open Access | Times Cited: 98
Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives
Stefania Cocco, Michela Piezzo, Alessandra Calabrese, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 13, pp. 4579-4579
Open Access | Times Cited: 96
PrimPol-dependent single-stranded gap formation mediates homologous recombination at bulky DNA adducts
Ann Liza Piberger, Akhil Bowry, Richard D. Kelly, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 94
Comprehensive ADP‐ribosylome analysis identifies tyrosine as an ADP‐ribose acceptor site
Deena M. Leslie Pedrioli, Mario Leutert, Vera Bilan, et al.
EMBO Reports (2018) Vol. 19, Iss. 8
Open Access | Times Cited: 92
Replication Stress, DNA Damage, Inflammatory Cytokines and Innate Immune Response
Sandrine Ragu, Gabriel Matos‐Rodrigues, Bernard S. López
Genes (2020) Vol. 11, Iss. 4, pp. 409-409
Open Access | Times Cited: 90
An HPF1/PARP1-Based Chemical Biology Strategy for Exploring ADP-Ribosylation
Juán José Bonfiglio, Orsolya Leidecker, Helen Dauben, et al.
Cell (2020) Vol. 183, Iss. 4, pp. 1086-1102.e23
Open Access | Times Cited: 90
Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide (AZD5305): A PARP1–DNA Trapper with High Selectivity for PARP1 over PARP2 and Other PARPs
Jeffrey W. Johannes, Amber Balazs, Derek Barratt, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 19, pp. 14498-14512
Closed Access | Times Cited: 90
Role of Rad51 and DNA repair in cancer: A molecular perspective
Erik Laurini, Domenico Marson, Alice Fermeglia, et al.
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107492-107492
Open Access | Times Cited: 88
Page 1 - Next Page

Scroll to top